secwatch / observer
8-K filed January 29, 2026, 6:59 PM ET ticker ESMC CIK 0000862668
other material confidence high sentiment positive materiality 0.73

ESCALON MEDICAL CORP (ESMC): M&A transaction — Escalon Medical sells AXIS software assets to Optos for $3M; receives first $1M milestone

ESCALON MEDICAL CORP

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

ESCALON MEDICAL CORP completed a disposition involving Optos Public Limited Company for aggregate purchase price of $3,000,000 (closed 2026-01-23).

Action
disposition
Counterparty
Optos Public Limited Company
Consideration
aggregate purchase price of $3,000,000
Closing
2026-01-23
Exact text from the filing
Company agreed to sell to Optos certain software-related assets associated with the Company’s AXIS platform (the “ Disposition ”) in exchange for the aggregate purchase price of $3,000,000. The purchase price is payable in three milestone installments, each in the amount and subject to the conditions as set forth in the Asset Purchase Agreement, in addition to
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

ESCALON MEDICAL CORP entered into Asset Purchase Agreement with Optos Public Limited Company valued at $3,000,000 (effective 2026-01-23).

Action
entry
Agreement
asset purchase
Counterparty
Optos Public Limited Company
Value
$3,000,000
Effective
2026-01-23
Exact text from the filing
edical Corp., a Pennsylvania corporation (the “ Company ”), is party to that certain Asset Purchase Agreement by and between the Company and Optos Public Limited Company, a company incorporated in Scotland (“ Optos ”) (as amended, the
View on SEC.gov

Browse all m&a transactions →

ESCALON MEDICAL CORP filing history →

Source: SEC EDGAR
accession 0001213900-26-009497
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.